一 中 亚 鹏 元 Csci Pengyuan 南京茂莱光学科技股份有限公司 向不特定对象发行可转换公司债 券信用评级报告 中鹏信评【2025】第 Z【449】号 02 21 6-10-1 信用评级报告声明 除因本次评级事项本评级机构与评级对象构成委托关系外,本评级机构及评级从业人员与评级对象不存 在任何足以影响评级行为独立、客观、公正的关联关系。 本评级机构与评级从业人员已履行尽职调查义务,有充分理由保证所出具的评级报告遵循了真实、客观、 公正原则,但不对评级对象及其相关方提供或已正式对外公布信息的合法性、真实性、准确性和完整性 作任何保证。 本评级机构依据内部信用评级标准和工作程序对评级结果作出独立判断,不受任何组织或个人的影响。 本评级报告观点仅为本评级机构对评级对象信用状况的个体意见,不作为购买、出售、持有任何证券的 建议。本评级机构不对任何机构或个人因使用本评级报告及评级结果而导致的任何损失负责。 本次评级结果自本评级报告所注明日期起生效,有效期为被评证券的存续期。同时,本评级机构已对受 评对象的跟踪评级事项做出了明确安排,并有权在被评证券存续期间变更信用评级。本评级机构提醒报 告使用者应及时登陆本 ...

本次会议的召开符合《中华人民共和国公司法》（以下简称《公司法》）等 法律、法规、部门规章以及《公司章程》的有关规定，会议决议合法、有效。 二、监事会会议审议情况 证券代码：688502 证券简称：茂莱光学 公告编号：2025-082 南京茂莱光学科技股份有限公司 第四届监事会第十五次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、 监事会会议召开情况 南京茂莱光学科技股份有限公司（以下简称"公司"）第四届监事会第十五次 会议于 2025 年 11 月 18 日在公司会议室以现场结合通讯的方式召开。本次会议 为紧急会议，经与会监事一致同意，豁免本次会议的通知时限。本次会议由监事 会主席陈海燕女士主持召开，会议应出席监事 3 人，实际出席 3 人。 （一）逐项审议通过《关于进一步明确公司向不特定对象发行可转换公司 债券方案的议案》 表决结果：同意 3 票，反对 0 票，弃权 0 票。议案审议通过。 1.3 票面金额和发行价格 公司已取得中国证券监督管理委员会出具的《关于同意南京茂莱光学科技股 份有限公司向不特 ...

证券代码：688502 证券简称：茂莱光学 公告编号：2025-081 南京茂莱光学科技股份有限公司 第四届董事会第十六次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、 董事会会议召开情况 该议案在提交至董事会审议前，已分别经董事会战略与发展委员会、审计委 员会审议通过。 该议案已经独立董事专门会议逐项审议通过。 公司已收到中国证券监督管理委员会出具的《关于同意南京茂莱光学科技股 份有限公司向不特定对象发行可转换公司债券注册的批复》（证监许可〔2025〕 2433 号），同意公司向不特定对象发行可转换公司债券（以下简称"本次发行"） 的注册申请。 公司董事会根据公司 2025 年第一次临时股东会的授权，以及相关法律、法 规和规范性文件的规定，结合公司的实际情况和市场状况，进一步明确了本次发 行的方案，出席会议的董事对本议案进行逐项审议，审议结果如下： 1.1 发行证券的种类 南京茂莱光学科技股份有限公司（以下简称"公司"）第四届董事会第十六次 会议于 2025 年 11 月 18 日在公司会议室以现场结 ...

Core Points - The Shanghai Composite Index closed at 3939.81 points, above the six-month moving average, with a decline of 0.81% [1] - The total trading volume of A-shares reached 1,945.96 billion yuan [1] - A total of 51 A-shares have surpassed the six-month moving average, with notable stocks showing significant deviation rates [1] Summary by Category Market Performance - The Shanghai Composite Index is currently at 3939.81 points, indicating a slight decline of 0.81% [1] - The total trading volume for A-shares today was 1,945.96 billion yuan [1] Stocks Surpassing Six-Month Moving Average - 51 A-shares have broken through the six-month moving average, with the highest deviation rates observed in: - Longxun Co., Ltd. with a deviation rate of 18.63% and a price increase of 20.00% [1] - Meideng Technology with a deviation rate of 14.56% and a price increase of 22.82% [1] - Jingchen Co., Ltd. with a deviation rate of 9.04% and a price increase of 11.90% [1] Additional Notable Stocks - Other stocks with significant performance include: - Guangyun Technology with a deviation rate of 8.67% and a price increase of 19.99% [1] - Qixin Group with a deviation rate of 8.30% and a price increase of 10.07% [1] - Haohan Deep Technology with a deviation rate of 6.70% and a price increase of 9.03% [1]

Group 1 - The core viewpoint of the news is the significant movement in the photoresist sector, with multiple companies experiencing sharp increases in stock prices [1] Group 2 - Tongyi Co., Ltd. saw its stock price surge to the daily limit [1] - KMTQ also reached the daily limit in trading [1] - Other companies such as Zhangjiang Hi-Tech, Maolai Optics, Xinlai Materials, Wavelength Optoelectronics, and Haili Co., Ltd. followed with notable increases in their stock prices [1]

证券代码：688502 证券简称：茂莱光学 南京茂莱光学科技股份有限公司 2025 年第三次临时股东会会议资料 2025 年 11 月 1 目录 | 年第三次临时股东会会议须知 2025 | 3 | | --- | --- | | 2025 年第三次临时股东会会议议程 | 6 | | 2025 年第三次临时股东会会议议案 | 8 | | 议案一：关于取消监事会、变更经营范围并修订《公司章程》的议案 | 8 | | 议案二：关于修订、制定及废止部分公司治理制度的议案 | 10 | | 议案三：关于调整部分董事、高管 2025 年度薪酬的议案 | 12 | 2 南京茂莱光学科技股份有限公司 四、会议开始后，由会议主持人宣布现场出席会议的股东人数及其所持有表 决权的股份总数，会议登记应当终止，在此之后进场的股东无权参与现场投票表 决。 五、按照会议通知上所列顺序审议、表决议案。 六、股东会推选计票、监票人选，表决结果由计票、监票人员推选代表当场 公布表决结果。 3 七、本次股东会采取现场投票和网络投票相结合的方式。股东会的议案采用 记名方式投票表决，股东以其所代表的有表决权的股份数额行使表决权，每一股 份享有一票表 ...

Core Viewpoint - Maolai Optical (688502.SH) is advancing its financing and expansion plan, having received approval for the issuance of convertible bonds totaling up to 563 million yuan, aimed at enhancing precision optical production and R&D [1][2]. Financing and Investment - The company plans to raise up to 563 million yuan through the issuance of convertible bonds, with net proceeds allocated to ultra-precision optical production, R&D projects, and working capital [2][4]. - The ultra-precision optical production project has a total investment of 417 million yuan, with up to 417 million yuan sourced from the bond proceeds, accounting for approximately 74% of the total fundraising [2][3]. - The ultra-precision optical technology R&D center project has a total investment of 125 million yuan, with up to 123 million yuan from the bond proceeds, representing about 22% of the total [3]. Financial Performance - For the first three quarters of 2025, Maolai Optical reported revenue of 503 million yuan, a year-on-year increase of 34.05%, and a net profit attributable to shareholders of 45.69 million yuan, up 86.57% [1][7]. - The company’s net profit excluding non-recurring items reached 38.92 million yuan, reflecting a growth of 109.45% [1][7]. - Revenue growth is primarily driven by the semiconductor sector and AR/VR testing fields, with the semiconductor sector accounting for 58.80% of total revenue [7]. R&D and Technological Capabilities - Maolai Optical emphasizes R&D, with investments increasing steadily from 54.40 million yuan in 2022 to 62.32 million yuan in the first three quarters of 2025, maintaining a high investment ratio relative to revenue [6]. - The company has developed five core technologies, including precision optical coating and high-precision optical assembly techniques, enhancing its competitive edge [6]. Strategic Partnerships and Market Position - The company has established long-term strategic partnerships with leading global tech firms and research institutions, including Google’s Waymo and Microsoft, enhancing its market position [7]. - New subsidiaries in Shenzhen and Beijing aim to focus on standard product development and local semiconductor industry support, respectively [4].

Group 1 - Digital Zhengtong's subsidiary Baoding Jindi won a bid for a smart water project in Jinan, with a total contract value of 109 million yuan, of which Baoding Jindi's share is approximately 77 million yuan [1] - Lingzhi Software plans to acquire 100% equity of Kaimiride through a combination of cash and stock issuance, with the final transaction price yet to be determined [1] - Tianjin Port's subsidiary plans to transfer 60% equity of China Railway Storage and Transportation, with an estimated value of 37.54 million yuan for the entire equity [2] Group 2 - New Wufeng reported a 56.97% year-on-year increase in pig sales in October, selling 610,000 pigs [3] - New Peng Co. announced a joint investment of approximately 15 million USD with Jabil to build a battery storage box project in Thailand [4] - Maiwei Bio received approval for a clinical trial of its 9MW3811 injection for pathological scars [6] Group 3 - Jiangsu Sopo completed maintenance and resumed production of its methanol and acetic acid facilities [8] - Luoniushan reported a 24.65% year-on-year increase in pig sales revenue in October, totaling 116 million yuan [9][10] - Zhongbei Communication signed a 1 billion yuan comprehensive computing service framework agreement with Xiamen Hongxin Electronics [11] Group 4 - Huayang New Materials announced the resignation of its general manager, Wu Yuehua [12] - Zhongxin Co. used 50 million yuan of idle funds to purchase structured deposits with expected annual returns between 0.55% and 2.05% [14] - Huajian Group's subsidiary signed a construction engineering design contract worth 96.54 million yuan [16] Group 5 - Jianyou Co. received FDA approval for a new production site for its injectable drug [17] - Beilu Pharmaceutical obtained a drug registration certificate for its iodine mepivacaine injection, which is included in the national medical insurance catalog [19] - *ST Yuancheng's stock will be suspended due to falling below the market cap threshold for delisting [20] Group 6 - Xiantan Co. reported a 9.3% year-on-year increase in chicken product sales revenue in October, totaling 503 million yuan [21] - Huanxu Electronics reported an 8.93% year-on-year decrease in consolidated revenue for October, amounting to 5.598 billion yuan [23] - Yisheng Co. reported a 22.97% year-on-year decrease in white feather chicken seed sales revenue in October [25] Group 7 - Yuandong Bio initiated a Phase I/II clinical trial for its ADC drug YLSH003 targeting advanced solid tumors [25] - Xiaoming Co. reported a 34.89% year-on-year decrease in chicken product sales revenue in October [26] - Nanjiao Food reported a 5.27% year-on-year decrease in consolidated revenue for October, totaling 235 million yuan [28] Group 8 - Chuangye Huikang announced a potential change in control, leading to a temporary stock suspension [30] - Tangrenshen reported a 17.91% year-on-year decrease in pig sales revenue in October, totaling 828 million yuan [32][33] - Wancheng Group plans to distribute a cash dividend of 1.5 yuan per 10 shares to shareholders [34] Group 9 - Kangguan Technology plans to distribute a cash dividend of 3.6 yuan per 10 shares to shareholders [36] - Shoudu Online's executive plans to reduce holdings of up to 19,400 shares [38] - Maolai Optical received approval for the issuance of convertible bonds [40] Group 10 - Jinkai New Energy plans to distribute a cash dividend of 0.1 yuan per share to shareholders [41] - Tianchen Medical raised the upper limit for share repurchase to 70 yuan per share [42] - Tianmu Lake used 38 million yuan of idle funds to purchase structured deposits [43]

Core Points - The stock of Maolai Optical (688502) closed at 357.82 yuan on November 10, 2025, down 0.89% from the previous trading day, with a total market capitalization of 18.893 billion yuan [1] - The company announced that it received approval from the China Securities Regulatory Commission (CSRC) for the issuance of convertible bonds to unspecified investors, valid for 12 months from the date of approval [1] Summary by Category Stock Performance - The stock opened at 360.0 yuan, reached a high of 365.0 yuan, and a low of 351.01 yuan, with a trading volume of 2.54 billion yuan and a turnover rate of 4.23% [1] Corporate Actions - The company will issue convertible bonds in accordance with the approved registration and will adhere to relevant laws and regulations, fulfilling disclosure obligations as required [1]

Core Points - The company, Maolai Optics, has received approval from the China Securities Regulatory Commission for the issuance of convertible bonds to unspecified investors [2] - The approval is valid for 12 months from the date of registration [2] - The issuance must strictly follow the application documents and issuance plan submitted to the Shanghai Stock Exchange [2]